Cat. #153358
Anti-Factor VIII [RFF-VIII:c/8]
Cat. #: 153358
Unit size: 100 ug
Availability: 10-12 weeks
Target: Factor VIII
Class: Recombinant
Application: IF ; Fn ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Alison Goodall
Institute: University College London (UCL) ; Absolute Antibody
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-Factor VIII [RFF-VIII:c/8]
- Clone: rRFF-VIII:c/8
- Class: Recombinant
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: IF ; Fn ; WB
- Description: The commonest severe congenital bleeding disorder in all races is haemophilia A. The characteristic defect is a lack of coagulation factor VIII:C. Factor VIII:C is a glycoprotein that functions as a cofactor for factor IXa which, in the presence of calcium and phospholipids, converts factor X to the activated form Xa. This antibody binds to human FVIII:C heavy chain and inhibits its function.
- Immunogen: Purified human factor VIII
- Isotype: IgG1 kappa
Target Details
- Target: Factor VIII
- Target background: The commonest severe congenital bleeding disorder in all races is haemophilia A. The characteristic defect is a lack of coagulation factor VIII:C. Factor VIII:C is a glycoprotein that functions as a cofactor for factor IXa which, in the presence of calcium and phospholipids, converts factor X to the activated form Xa. This antibody binds to human FVIII:C heavy chain and inhibits its function.
Applications
- Application: IF ; Fn ; WB
Handling
- Format: Liquid
- Concentration: 1mg/ml
- Unit size: 100 ug
- Storage buffer: RPMI + 10% FCS; non-adherent; subculture every 2-3 days; split 1:5
- Shipping conditions: Shipping at 4° C
References
- Goodall AH et al. 1985. Thromb Haemost. 54(4):878-91. PMID: 3937279 Rotblat F et al. 1983. J Lab Clin Med. 101(5):736-46. PMID: 6403638 [RFF-VIII:c/8 was used to purify FVIII for this landmark study] Rotblat F et al. 1985. Biochemistry. 24(16):4294-300. PMID: 2413885 Takase T et al. 1987. Br J Haematol. 66(4):497-502.PMID: 3117089 Vehar GA et al. 1984. Nature. 1984 312(5992):337-42. PMID: 6438527